Immune dysfunction in nucleotide excision repair disorders: an underrecognized clinical phenotype with relevance for inborn errors of immunity - Scorecard - MDSpire

Immune dysfunction in nucleotide excision repair disorders: an underrecognized clinical phenotype with relevance for inborn errors of immunity

  • By

  • Raphael Rossmanith

  • Hermann M. Wolf

  • Christoph B. Geier

  • July 3, 2026

  • 0 min

Share

Clinical Scorecard: Immune System Impairment in Nucleotide Excision Repair Disorders: A Frequently Overlooked Clinical Manifestation with Implications for Genetic Immune Deficiencies

At a Glance

CategoryDetail
ConditionNucleotide Excision Repair Disorders
Key MechanismsImpaired DNA repair and transcriptional capacity affecting immune function.
Target PopulationPatients with xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.
Care SettingClinical and immunological assessment of genetic immune deficiencies.

Key Highlights

  • Immune dysfunction is an underrecognized component of NER disorders.
  • Clinical findings include impaired vaccine responses and hypogammaglobulinemia.
  • Specific immune abnormalities are more prominent in transcription-associated NER defects.
  • Recurrent infections and increased morbidity reported in patients with TTD.
  • Molecular diagnostics have enabled systematic evaluation of immune function in NER cohorts.

Guideline-Based Recommendations

Diagnosis

  • Systematic immunological assessment in genetically defined NER cohorts.

Management

  • Monitor immune function and consider immunological assessment in NER patients.

Monitoring & Follow-up

  • Evaluate vaccine responses and immune cell populations regularly.

Risks

  • Increased risk of infections and infection-related morbidity in NER disorders.

Patient & Prescribing Data

Individuals with inherited defects in NER genes.

Consider immunological evaluation and management strategies tailored to immune dysfunction.

Clinical Best Practices

  • Recognize immune dysfunction as a significant aspect of NER disorders.
  • Implement standardized immunophenotyping for affected patients.
  • Focus on both dermatologic and immunological manifestations in clinical assessments.

Related Resources & Content

Original Source(s)

Related Content